Phase 2 study to compare INBRX-101 to plasma derived A1PI therapy in adults with AATD emphysema
- Investigator
- Jorge E Lascano
- Status
- Accepting Candidates
- Ages
- 18 Years - 80 Years
- Sexes
- All
Research at a glance
Top areas of exploration
- alpha 1-Antitrypsin Deficiency , 9 publications
- Pulmonary Disease, Chronic Obstructive , 8 publications
- alpha 1-Antitrypsin , 7 publications
- Phenotype , 3 publications
Research activity
Active clinical trials
- Investigator
- Jorge E Lascano
- Status
- Accepting Candidates
The purpose of this study is to evaluate the safety and tolerability of 72 milligrams per kilogram (mg/kg) and 180 mg/kg Alpha-1 15%, administered as a single-dose subcutaneous (SC) infusion and subsequently as weekly SC infusions over 8 weeks in…
- Investigator
- Jorge E Lascano
- Status
- Accepting Candidates
- Ages
- 18 Years - 80 Years
- Sexes
- All
My publications
Filter publications
41 publications
2022
Evaluation of Clinical Predictors for Major Outcomes in Patients Hospitalized With COVID-19: The Potential Role of the Rothman Index.
Cureus
PubMed • Publisher's site2022
Labelling Alpha-1 antitrypsin deficiency in the medical record - A call to action.
Respiratory medicine
PubMed • Publisher's site2022
Outcomes and survival following lung transplantation in non-cystic fibrosis bronchiectasis
ERJ Open Research
PubMed • Publisher's site2022
Overuse of Pulmonary Function Tests: A Cohort of "Superusers".
American journal of medical quality : the official journal of the American College of Medical Quality
PubMed • Publisher's site2022
Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial.
Thorax
PubMed • Publisher's site